Global leader in organ-on-a-chip technology backed by international syndicate for worldwide commercial expansion and new product development Leiden, the Netherlands — MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. MIMETAS will use the proceeds of this Series B financing round to expand […]
UTRECHT, THE NETHERLANDS MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%. “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms that it enables […]
New grants will accelerate DNA Script’s commercialization of its novel high speed, high efficiency, free-of-harsh-chemicals DNA synthesis technology. Paris, France – DNA Script today announced awards totaling $5.5M in non-dilutive financing from the highly selective Horizon 2020 European Innovation Council program of the European Commission and the Aide au développement de l’innovation and Concours Mondial d’innovation programs of Bpifrance. DNA Script […]
Connection Capital, the specialist private client investment business, has raised £5.9m from its private investor clients to invest in a specialist laboratory equipment manufacturer with a global blue chip client base. HEL Ltd (HEL) designs and supplies a range of custom-made modular lab instruments and testing equipment. Typical products include different forms of “reaction stations” […]
SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the completion of a private placement of $50 million, bringing the total raised to $259 million since the company’s founding in 2013. “We have used our proprietary DNA synthesis platform, which delivers precision at […]
Exclusive two-way licensing deal promises to accelerate growth for both companies Frederick, MD — Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to reaserchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class […]
Funding will support new manufacturing facility, commercial expansion, and development of new innovative products. Oxford, UK. Oxford Nanopore Technologies Ltd, the company behind the only portable real-time DNA/RNA sequencer, MinION, has raised £100M ($140M) in new investment. Funds were raised from global investors including GIC (Singapore), CCB International (CCBI, China), Hostplus (Australia), and existing investors. The […]
Lawrence, MA — Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners. The funding will be primarily used to support Nexcelom’s worldwide growth initiatives. Founded in 2003, Nexcelom is a fast-growing supplier of innovative […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the launch of a private placement of up to 4.74 million new shares to institutional investors in Europe. The price per share is set to EUR 1.40, based on a weighted average XETRA closing price of the Sygnis AG […]
Investment will grow company’s expert team, accelerate development and commercialization of gene-editing tools — including enzymes, reagents, instrumentation, and software Boulder, Colo. – Inscripta, a leading gene-editing technology company, today announced that it has closed a $55.5 million Series C funding round led by Mérieux Développement and Paladin Capital Group. Additional participants include all existing Inscripta […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
